These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
379 related articles for article (PubMed ID: 10409758)
1. Neoplastic transformation of RK3E by mutant beta-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expression. Kolligs FT; Hu G; Dang CV; Fearon ER Mol Cell Biol; 1999 Aug; 19(8):5696-706. PubMed ID: 10409758 [TBL] [Abstract][Full Text] [Related]
2. gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin. Kolligs FT; Kolligs B; Hajra KM; Hu G; Tani M; Cho KR; Fearon ER Genes Dev; 2000 Jun; 14(11):1319-31. PubMed ID: 10837025 [TBL] [Abstract][Full Text] [Related]
3. Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer. Caca K; Kolligs FT; Ji X; Hayes M; Qian J; Yahanda A; Rimm DL; Costa J; Fearon ER Cell Growth Differ; 1999 Jun; 10(6):369-76. PubMed ID: 10392898 [TBL] [Abstract][Full Text] [Related]
4. ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with beta-catenin defects and promotes neoplastic transformation. Kolligs FT; Nieman MT; Winer I; Hu G; Van Mater D; Feng Y; Smith IM; Wu R; Zhai Y; Cho KR; Fearon ER Cancer Cell; 2002 Mar; 1(2):145-55. PubMed ID: 12086873 [TBL] [Abstract][Full Text] [Related]
5. Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling. Leung JY; Kolligs FT; Wu R; Zhai Y; Kuick R; Hanash S; Cho KR; Fearon ER J Biol Chem; 2002 Jun; 277(24):21657-65. PubMed ID: 11940574 [TBL] [Abstract][Full Text] [Related]
6. Signaling through beta-catenin and Lef/Tcf. Novak A; Dedhar S Cell Mol Life Sci; 1999 Oct; 56(5-6):523-37. PubMed ID: 11212302 [TBL] [Abstract][Full Text] [Related]
7. Nuclear endpoint of Wnt signaling: neoplastic transformation induced by transactivating lymphoid-enhancing factor 1. Aoki M; Hecht A; Kruse U; Kemler R; Vogt PK Proc Natl Acad Sci U S A; 1999 Jan; 96(1):139-44. PubMed ID: 9874785 [TBL] [Abstract][Full Text] [Related]
8. Tcf-1-mediated transcription in T lymphocytes: differential role for glycogen synthase kinase-3 in fibroblasts and T cells. Staal FJ; Burgering BM; van de Wetering M; Clevers HC Int Immunol; 1999 Mar; 11(3):317-23. PubMed ID: 10221643 [TBL] [Abstract][Full Text] [Related]
9. A yeast model system for functional analysis of beta-catenin signaling. Lee MS; D'Amour KA; Papkoff J J Cell Biol; 2002 Sep; 158(6):1067-78. PubMed ID: 12235124 [TBL] [Abstract][Full Text] [Related]
10. Regulation of lymphoid enhancer factor 1/T-cell factor by mitogen-activated protein kinase-related Nemo-like kinase-dependent phosphorylation in Wnt/beta-catenin signaling. Ishitani T; Ninomiya-Tsuji J; Matsumoto K Mol Cell Biol; 2003 Feb; 23(4):1379-89. PubMed ID: 12556497 [TBL] [Abstract][Full Text] [Related]
11. A GSK3beta phosphorylation site in axin modulates interaction with beta-catenin and Tcf-mediated gene expression. Jho Eh; Lomvardas S; Costantini F Biochem Biophys Res Commun; 1999 Dec; 266(1):28-35. PubMed ID: 10581160 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells. Tan C; Costello P; Sanghera J; Dominguez D; Baulida J; de Herreros AG; Dedhar S Oncogene; 2001 Jan; 20(1):133-40. PubMed ID: 11244511 [TBL] [Abstract][Full Text] [Related]
13. TIP49 regulates beta-catenin-mediated neoplastic transformation and T-cell factor target gene induction via effects on chromatin remodeling. Feng Y; Lee N; Fearon ER Cancer Res; 2003 Dec; 63(24):8726-34. PubMed ID: 14695187 [TBL] [Abstract][Full Text] [Related]
14. The Yin-Yang of TCF/beta-catenin signaling. Barker N; Morin PJ; Clevers H Adv Cancer Res; 2000; 77():1-24. PubMed ID: 10549354 [TBL] [Abstract][Full Text] [Related]
15. Wnt-1 but not epidermal growth factor induces beta-catenin/T-cell factor-dependent transcription in esophageal cancer cells. Mizushima T; Nakagawa H; Kamberov YG; Wilder EL; Klein PS; Rustgi AK Cancer Res; 2002 Jan; 62(1):277-82. PubMed ID: 11782388 [TBL] [Abstract][Full Text] [Related]
16. The Wnt/Wg signal transducer beta-catenin controls fibronectin expression. Gradl D; Kühl M; Wedlich D Mol Cell Biol; 1999 Aug; 19(8):5576-87. PubMed ID: 10409747 [TBL] [Abstract][Full Text] [Related]
17. Suppression of glycogen synthase kinase activity is not sufficient for leukemia enhancer factor-1 activation. Yuan H; Mao J; Li L; Wu D J Biol Chem; 1999 Oct; 274(43):30419-23. PubMed ID: 10521419 [TBL] [Abstract][Full Text] [Related]
18. Regulation of beta -catenin transformation by the p300 transcriptional coactivator. Sun Y; Kolligs FT; Hottiger MO; Mosavin R; Fearon ER; Nabel GJ Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12613-8. PubMed ID: 11050151 [TBL] [Abstract][Full Text] [Related]
19. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Satoh S; Daigo Y; Furukawa Y; Kato T; Miwa N; Nishiwaki T; Kawasoe T; Ishiguro H; Fujita M; Tokino T; Sasaki Y; Imaoka S; Murata M; Shimano T; Yamaoka Y; Nakamura Y Nat Genet; 2000 Mar; 24(3):245-50. PubMed ID: 10700176 [TBL] [Abstract][Full Text] [Related]
20. Lef/Tcf-dependent Wnt/beta-catenin signaling during Xenopus axis specification. Geng X; Xiao L; Lin GF; Hu R; Wang JH; Rupp RA; Ding X FEBS Lett; 2003 Jul; 547(1-3):1-6. PubMed ID: 12860376 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]